FDA Clears PulseAI’s AI for Wearable ECG Interpretation
Reported by Medical Device News Magazine and Tech Times2 sources ↓
Belfast startup PulseAI says the FDA cleared its cloud-based AI for interpreting wearable single-lead ECGs. Tech Times reports a 296-participant study found fewer inconclusive results than the Apple Watch’s native algorithm.
Key points
- The study compared PulseAI’s algorithm with the Apple Watch’s native algorithm
- Tech Times reports the inconclusive rate fell from roughly 20% to under 1%
- The cloud-based system is designed to work with compatible ECG devices and software platforms
Sources
Details
PulseAI announced 510(k) clearance for its AI-powered arrhythmia analysis model. The company says compatible devices send ECG recordings to its cloud service, which returns structured results to a connected application for clinical review.
The 296-participant study was published in Heart Rhythm. Medical Device News Magazine and Tech Times report a 92% reduction in inconclusive interpretations compared with the Apple Watch’s native algorithm; Tech Times says the rate fell from roughly 20% to under 1%.
Written from coverage as of
Images
- Medical Device News Magazine
- Tech Times
Stocks in this story
Change since open: 20 Nov to 21 Nov 2026
Last refresh